GW742 Pellets (PPARĪ“ Agonist)
GW0742 Pellets are a high-purity research compound formulated for advanced studies targeting metabolic regulation, cardiovascular health, and inflammation. These pellets are a potent agonist of the peroxisome proliferator-activated receptor delta (PPARĪ“), offering precise control and sustained delivery for both in vitro and in vivo applications. This isn’t a SARM, but you can follow this link to browse our SARM range: buy sarms uk
Product Features and Specifications
- Chemical Formula: C21H17ClN2O4S2
- Molecular Weight: 460.96 g/mol
- Form: Off-white, stable pellets optimized for controlled release.
- Purity: ā„99% by HPLC.
- Solubility: Soluble in DMSO, ethanol, and other polar organic solvents.
- Storage Conditions: Maintain at -20Ā°C in a desiccated, light-protected environment to ensure long-term stability.
Applications
GW0742 Pellets are highly suitable for research in:
- Metabolic Disorders: Investigating PPARĪ“ modulation in fatty acid oxidation, glucose metabolism, and insulin sensitivity.
- Cardiovascular Health: Evaluating roles in vascular function, lipid profiles, and atherogenesis.
- Inflammation and Immunology: Examining anti-inflammatory pathways in chronic diseases and autoimmune conditions.
- Exercise Physiology: Understanding PPARĪ“-driven enhancements in endurance and skeletal muscle efficiency.
Research Insights
Numerous studies highlight the significance of GW0742 as a research tool:
- Metabolic Regulation: Studies show GW0742 enhances fatty acid oxidation and reduces triglyceride levels, making it a promising candidate for investigating therapies for obesity and type 2 diabetes (Oliver et al., 2001).
- Cardiovascular Health: Research demonstrates that GW0742 modulates vascular inflammation and improves endothelial function, offering a basis for exploring treatments for atherosclerosis (Barish et al., 2006).
- Anti-Inflammatory Effects: GW0742 has shown to attenuate pro-inflammatory cytokine release in preclinical models, underlining its potential in autoimmune and chronic inflammatory diseases (Grygiel-GĆ³rniak, 2014).
- Exercise Mimetic Properties: Animal studies reveal that PPARĪ“ activation via GW0742 improves running endurance and skeletal muscle fiber remodeling, suggesting potential relevance in exercise physiology and age-related muscle decline (Narkar et al., 2008).
These findings highlight GW0742’s utility in foundational research aimed at uncovering therapeutic pathways for widespread metabolic and inflammatory conditions.
Handling and Safety
- Intended Use: For research purposes only. Not for human or veterinary use.
- Safety Precautions: Handle under strict laboratory safety protocols. Use PPE, including gloves and goggles, to avoid accidental exposure.
- MSDS: Material Safety Data Sheet available upon request for detailed safety and handling guidelines.
Packaging and Customization
- Available in 5 mg, 10 mg, and 50 mg pellet formats.
- Bulk quantities and custom packaging configurations can be provided upon request.
Technical Support
Maxmusclelabs offers dedicated technical support to optimize research outcomes using GW0742. Contact our team for assistance with protocols, analytical methods, or troubleshooting.
